Welltower, Inc.

As of July 28, 2025, Welltower, Inc. is considered expensive with high valuation ratios, indicating it may be overvalued despite a strong year-to-date return of 32.14%.

As of June 20, 2025, Welltower, Inc. exhibits a mildly bullish trend, supported by bullish daily moving averages and mixed weekly indicators, despite some caution from the MACD and KST.

As of February 11, 2025, Welltower, Inc. is considered very expensive and overvalued with a high P/E ratio of 83 and low returns on capital and equity, suggesting that its stock price may not be justified despite recent strong performance.

As of March 2022, the management team of Welltower, Inc. includes Kenneth Bacon (Non-Executive Chairman), Shankh Mitra (CEO and Chief Investment Officer), Jeffrey Donahue (Lead Independent Director), Philip Hawkins, Diana Reid, and Karen DeSalvo (Independent Director). They are responsible for the company's strategic direction and operations.

Welltower, Inc. is a real estate investment trust (REIT) focused on seniors housing and healthcare real estate, with a market capitalization of approximately $97.4 billion. As of March 2025, it reported net sales of $2.42 billion and a net profit of $257 million.

As of Jun 18, Welltower, Inc. has a market capitalization of $97.40 billion, with net sales of $8.55 billion and a net profit of $1.10 billion for the latest four quarters. The balance sheet shows shareholder's funds of $31.96 billion and total assets of $51.04 billion.